TSE •
Healthcare •
Biotechnology •
Quote as of 07/28/2026 15:30
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeTSE
Market Capitalization4,576.16 mln
Float47.25 mln
Earnings Date08/07/2025
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-3.05
Reliable
Relative Strength
13
/ 100
Significantly lagging
Debt / Equity
0.45
Low leverage
ROE
-29.12
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Founded in 1999 and based in Nagoya, Japan, D. Western Therapeutics Institute Inc. is a biotechnology firm dedicated to creating new medicines for eye diseases and other medical conditions. Its lineup includes treatments for glaucoma, cataracts, and corneal disorders, as well as a skin patch for nerve pain caused by shingles. Several of its products are already on the market, while others are currently moving through clinical trials.
